Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Gray

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Oncogene|October 14, 2003
Molecular subclassification of kidney tumors and the discovery of new diagnostic markersMasayuki Takahashi, Ximing J Yang, Jun Sugimura, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independentJane L Hurwitz, Izabela Stasik, Emma M Kerr, et al.
Journal of Neuroimmunology|May 12, 2005
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitisSandra Camelo, Antonio H Iglesias, Daehee Hwang, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLCSarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2025
Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective CohortCiara S McNevin, Anna Keogh, Mutaz Mohammed Nur, et al.
Clinical Chemistry|March 21, 2022
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast CancerTony Loughman, Stephen Barron, Chan-Ju Angel Wang, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
JCO Precision Oncology|February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape ProjectMartina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2023
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma DatabaseIsabelle Opitz, Andrea Bille, Urania Dafni, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Oncogene|October 14, 2003
Molecular subclassification of kidney tumors and the discovery of new diagnostic markersMasayuki Takahashi, Ximing J Yang, Jun Sugimura, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independentJane L Hurwitz, Izabela Stasik, Emma M Kerr, et al.
Journal of Neuroimmunology|May 12, 2005
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitisSandra Camelo, Antonio H Iglesias, Daehee Hwang, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLCSarah-Louise Ryan, Sam Beard, Martin P Barr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2025
Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective CohortCiara S McNevin, Anna Keogh, Mutaz Mohammed Nur, et al.
Clinical Chemistry|March 21, 2022
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast CancerTony Loughman, Stephen Barron, Chan-Ju Angel Wang, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
JCO Precision Oncology|February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape ProjectMartina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2023
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma DatabaseIsabelle Opitz, Andrea Bille, Urania Dafni, et al.
Pageof 11